NorthWest Biotherapeutics Inc (NWBO)

[Rkmatters]

It's a fair topic to discuss how press releases affect stock prices.

My perception from reading AF's post and articles is that his view is that he's correct, and that the DCVax-L product is not much better, if any, from a placebo. He also expressed that NWBT designed the Ph III study with an improper endpoint starting out, so the trial is doomed to fail in his opinion. His motivation is to impress that point on investors so they stay away from the stock or sell out and move on if they're in. I don't know if I can agree that his motivation is that his articles bankrupt the company or help the shorts. He prefers to write about them for years to come, they sell headlines. They allow for interesting debates. He's never bored.

My view on the press releases in general, pro and con:

NWBT writes press releases to accentuate their potential positives, whether actual or apparent, real or imagined.

AF writes press releases to accentuate the Company's negatives whether actual or apparent, real or imagined.

Both at times write in speculator fashion. The whole truth I imagine lies somewhere in the middle. It isn't as glowing as NWBT makes it out to be, nor is it as dark as AF makes it out to be.

Conspiracy theories, I disagree with. But, of course they're open to discussion. I try not to partake.